Chances and limitations of chemotherapy in elderly patients

被引:0
|
作者
Wedding, U. [1 ]
机构
[1] Univ Klinikum Jena, Klin Innere Med 2, Abt Palliat Med, D-07747 Jena, Germany
来源
INTERNIST | 2010年 / 51卷 / 03期
关键词
Chemotherapy; Elderly; Co-morbidity; Functional status; Geriatric assessment; COMPREHENSIVE GERIATRIC ASSESSMENT; ADJUVANT CHEMOTHERAPY; BREAST-CANCER; OLDER WOMEN; POOLED ANALYSIS; COLON-CANCER; PHASE-III; AGE; SURVIVAL; PARTICIPATION;
D O I
10.1007/s00108-010-2601-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The chronological age of a patient should not be a barrier to apply chemotherapy. Elderly patients can benefit from chemotherapy. Chronological age should not be a reason for diagnostic or therapeutic nihilism, as the age of a patient poorly characterizes their health situation. Data with high level of evidence on treatment of elderly patients with cancer are limited. A comprehensive geriatric assessment (CGA) describes the individual deficits and resources of a patient much better. Limitations in CGA are risk factors for increased toxicity and decreased treatment benefit. The currently available data demonstrate under- and over-treatment in elderly patients with cancer.
引用
收藏
页码:402 / +
页数:6
相关论文
共 50 条